Cargando…

Aptamer-facilitated Protection of Oncolytic Virus from Neutralizing Antibodies

Oncolytic viruses promise to significantly improve current cancer treatments through their tumor-selective replication and multimodal attack against cancer cells. However, one of the biggest setbacks for oncolytic virus therapy is the intravenous delivery of the virus, as it can be cleared from the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muharemagic, Darija, Zamay, Anna, Ghobadloo, Shahrokh M, Evgin, Laura, Savitskaya, Anna, Bell, John C, Berezovski, Maxim V
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4078759/ https://www.ncbi.nlm.nih.gov/pubmed/24892725 http://dx.doi.org/10.1038/mtna.2014.19

Ejemplares similares

Aptamers Selected to Postoperative Lung Adenocarcinoma Detect Circulating Tumor Cells in Human Blood
por: Zamay, Galina S, et al.
Publicado: (2015)

Detection of Cryptosporidium parvum Oocysts on Fresh Produce Using DNA Aptamers
por: Iqbal, Asma, et al.
Publicado: (2015)

Carbohydrate-Based Ice Recrystallization Inhibitors Increase Infectivity and Thermostability of Viral Vectors
por: Ghobadloo, Shahrokh M., et al.
Publicado: (2014)

Nucleic Acid Aptamers for Molecular Therapy of Epilepsy and Blood-Brain Barrier Damages
por: Zamay, Tatiana N., et al.
Publicado: (2019)

The proteomic analysis of breast cell line exosomes reveals disease patterns and potential biomarkers
por: Risha, Yousef, et al.
Publicado: (2020)

Aptamers Enhance Oncolytic Viruses’ Antitumor Efficacy
por: Dymova, Maya A., et al.
Publicado: (2022)

Aptamer-Targeted Plasmonic Photothermal Therapy of Cancer
por: Kolovskaya, Olga S., et al.
Publicado: (2017)

DNA Aptamers for the Characterization of Histological Structure of Lung Adenocarcinoma
por: Zamay, Galina S., et al.
Publicado: (2017)

Proof-of-principle that a decoy virus protects oncolytic measles virus against neutralizing antibodies
por: Xu, Chun, et al.
Publicado: (2018)

Parking CAR T Cells in Tumours: Oncolytic Viruses as Valets or Vandals?
por: Evgin, Laura, et al.
Publicado: (2021)

Development of DNA Aptamers to Native EpCAM for Isolation of Lung Circulating Tumor Cells from Human Blood
por: Zamay, Galina S., et al.
Publicado: (2019)

Aptamers Increase Biocompatibility and Reduce the Toxicity of Magnetic Nanoparticles Used in Biomedicine
por: Zamay, Galina S., et al.
Publicado: (2020)

Aptamer-Conjugated Superparamagnetic Ferroarabinogalactan Nanoparticles for Targeted Magnetodynamic Therapy of Cancer
por: Kolovskaya, Olga S., et al.
Publicado: (2020)

Aptamers for CD Antigens: From Cell Profiling to Activity Modulation
por: Nozari, Amin, et al.
Publicado: (2017)

In Vivo Cancer Cells Elimination Guided by Aptamer-Functionalized Gold-Coated Magnetic Nanoparticles and Controlled with Low Frequency Alternating Magnetic Field
por: Belyanina, Irina V., et al.
Publicado: (2017)

Current and Prospective Protein Biomarkers of Lung Cancer
por: Zamay, Tatiana N., et al.
Publicado: (2017)

The role of SAXS and molecular simulations in 3D structure elucidation of a DNA aptamer against lung cancer
por: Morozov, Dmitry, et al.
Publicado: (2021)

(11)C-radiolabeled aptamer for imaging of tumors and metastases using positron emission tomography- computed tomography
por: Ozerskaya, Anastasia V., et al.
Publicado: (2021)

Aptamers Regulating the Hemostasis System
por: Vaganov, Anatoly A., et al.
Publicado: (2022)

Virus–Receptor Interactions and Virus Neutralization: Insights for Oncolytic Virus Development
por: Jayawardena, Nadishka, et al.
Publicado: (2020)

Selection of aptamers for a protein target in cell lysate and their application to protein purification
por: Javaherian, Sahar, et al.
Publicado: (2009)

Generation of novel oncolytic vaccinia virus with improved intravenous efficacy through protection against complement-mediated lysis and evasion of neutralization by vaccinia virus-specific antibodies
por: Lee, Namhee, et al.
Publicado: (2023)

Monitoring of breast cancer progression via aptamer-based detection of circulating tumor cells in clinical blood samples
por: Kolovskaya, Olga S., et al.
Publicado: (2023)

Generation of a Tumor-Specific Chemokine Gradient Using Oncolytic Vesicular Stomatitis Virus Encoding CXCL9
por: Eckert, Elizabeth C., et al.
Publicado: (2019)

Aptamer-Conjugated Tb(III)-Doped Silica Nanoparticles for Luminescent Detection of Leukemia Cells
por: Grechkin, Yaroslav A., et al.
Publicado: (2020)

Electrochemical aptasensor for lung cancer-related protein detection in crude blood plasma samples
por: Zamay, Galina S., et al.
Publicado: (2016)

Positioning SUMO as an immunological facilitator of oncolytic viruses for high-grade glioma
por: Karandikar, Paramesh V., et al.
Publicado: (2023)

Discovery of DNA aptamers targeting SARS-CoV-2 nucleocapsid protein and protein-binding epitopes for label-free COVID-19 diagnostics
por: Poolsup, Suttinee, et al.
Publicado: (2023)

Oncolytic Viruses: Therapeutics With an Identity Crisis
por: Breitbach, Caroline J., et al.
Publicado: (2016)

Moving oncolytic viruses into the clinic: clinical-grade production, purification, and characterization of diverse oncolytic viruses
por: Ungerechts, Guy, et al.
Publicado: (2016)

Oncolytic Viruses
por: Chen, Nanhai G., et al.
Publicado: (2012)

Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
por: Bootz, Anna, et al.
Publicado: (2017)

Proteomics-Based Regression Model for Assessing the Development of Chronic Lymphocytic Leukemia
por: Bakhtina, Varvara I., et al.
Publicado: (2021)

Potentiation of immunomodulatory antibody therapy with oncolytic viruses for treatment of cancer
por: Zamarin, Dmitriy, et al.
Publicado: (2014)

Immunovirotherapy: The role of antibody based therapeutics combination with oncolytic viruses
por: Jafari, Mahdie, et al.
Publicado: (2022)

Prime-boost using Separate Oncolytic Viruses in Combination with Checkpoint Blockade Improves Anti-tumor Therapy
por: Ilett, Elizabeth, et al.
Publicado: (2016)

Oncolytic virus-derived type I interferon restricts CAR T cell therapy
por: Evgin, Laura, et al.
Publicado: (2020)

Glycoprotein N of Human Cytomegalovirus Protects the Virus from Neutralizing Antibodies
por: Kropff, Barbara, et al.
Publicado: (2012)

Lack of protection in vivo with neutralizing monoclonal antibodies to transmissible gastroenteritis virus
por: Wesley, R.D., et al.
Publicado: (1988)

Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protection
por: Brouwer, Philip J.M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cu2jtq7jqtahikao13imi9srlt